Meeting
2023 ASCO Annual Meeting
Association of social vulnerability with delays in starting guideline-adherent adjuvant therapy among patients with head and neck cancer.
Authors
Joshua Lee Cagle
Medical University of South Carolina, Charleston, SC
Joshua Lee Cagle , Salma Ramadan , Kavita Prasad , Flora Yan , John Pearce , Angela Liu Mazul , Elizabeth Goodwin Hill , Bhishamjit S. Chera , Katherine R. Sterba , Chanita Hughes-Halbert , Samantha Tam , Michael Topf , Vlad Sandulache , Sidharth Puram , Evan Michael Graboyes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Access to Care
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6523)
DOI
10.1200/JCO.2023.41.16_suppl.6523
Abstract #
6523
Poster Bd #
15
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
First Author: Robert L. Ferris
Poster
2022 ASCO Annual Meeting
Machine learning (ML)–enabled, circulating tumor cell–based classification of patients for non-prerequisite adjuvant therapy.
First Author: Gowhar Shafi
Poster
2017 ASCO Annual Meeting
Association of delayed adjuvant therapy and overall survival in early stage endometrial cancer.
First Author: Leo Luo
Poster
2024 ASCO Annual Meeting
Neoadjuvant adebrelimab plus dalpiciclib in HPV-negative locally advanced head and neck squamous cell carcinoma: A phase II clinical trial.
First Author: Lei Liu